Your browser doesn't support javascript.
loading
Messing with ßc: A unique receptor with many goals.
Kan, Winnie L; Cheung Tung Shing, Karen S; Nero, Tracy L; Hercus, Timothy R; Tvorogov, Denis; Parker, Michael W; Lopez, Angel F.
Affiliation
  • Kan WL; The Centre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, South Australia 5000, Australia. Electronic address: winnie.kan@sa.gov.au.
  • Cheung Tung Shing KS; Department of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria 3010, Australia. Electronic address: kcheung1@unimelb.edu.au.
  • Nero TL; Department of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria 3010, Australia. Electronic address: tracy.nero@unimelb.edu.au.
  • Hercus TR; The Centre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, South Australia 5000, Australia. Electronic address: tim.hercus@sa.gov.au.
  • Tvorogov D; The Centre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, South Australia 5000, Australia. Electronic address: denis.tvorogov@sa.gov.au.
  • Parker MW; Department of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria 3010, Australia; Australian Cancer Research Foundation Rational Drug Discovery Centre, St. Vincent's Institute of Medical Research, Fitzroy, Victoria 3065, A
  • Lopez AF; The Centre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, South Australia 5000, Australia; Department of Medicine, University of Adelaide, Adelaide, South Australia 5000, Australia; Australian Cancer Research Foundation Cancer Genomics Facility, SA Pathology, Adela
Semin Immunol ; 54: 101513, 2021 04.
Article in En | MEDLINE | ID: mdl-34836771
ABSTRACT
Our understanding of the biological role of the ßc family of cytokines has evolved enormously since their initial identification as bone marrow colony stimulating factors in the 1960's. It has become abundantly clear over the intervening decades that this family of cytokines has truly astonishing pleiotropic capacity, capable of regulating not only hematopoiesis but also many other normal and pathological processes such as development, inflammation, allergy and cancer. As noted in the current pandemic, ßc cytokines contribute to the cytokine storm seen in acutely ill COVID-19 patients. Ongoing studies to discover how these cytokines activate their receptor are revealing insights into the fundamental mechanisms that give rise to cytokine pleiotropy and are providing tantalizing glimpses of how discrete signaling pathways may be dissected for activation with novel ligands for therapeutic benefit.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 / Goals Type of study: Prognostic_studies Limits: Humans Language: En Journal: Semin Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 2021 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 / Goals Type of study: Prognostic_studies Limits: Humans Language: En Journal: Semin Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 2021 Document type: Article